Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Experimental Gerontology|December 28, 2005
Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging miceNigel Irwin, Brian D Green, Victor A Gault, et al.
Diabetes, Obesity & Metabolism|October 11, 2023
Sustained metabolic benefits of ΔTRTX-Ac1, a tarantula venom-derived peptide, when administered together with exenatide in high-fat fed miceAimee Coulter-Parkhill, Neil Tanday, Diego Cobice, et al.
Diabetes/Metabolism Research and Reviews|December 1, 2018
Exendin-4(Lys27 PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) miceAnnie Hasib, Ming T Ng, Neil Tanday, et al.
Biochemical Pharmacology|June 16, 2009
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic propertiesBarry D Kerr, Nigel Irwin, Finbarr P M O'Harte, et al.
European Journal of Pharmacology|September 2, 2006
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1Brian D Green, Nigel Irwin, Nicola A Duffy, et al.
Regulatory Peptides|May 6, 2006
Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16)Nigel Irwin, Brian D Green, Jeremy C Parker, et al.
Diabetologia|June 26, 2014
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activationAisling M Lynch, Nupur Pathak, Varun Pathak, et al.
Biochemical and Biophysical Research Communications|November 4, 2004
NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amideIñigo Alaña, Chandralal M Hewage, J Paul G Malthouse, et al.
Plos One|April 1, 2016
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone XeninChristine M Martin, Vadivel Parthsarathy, Annie Hasib, et al.
European Journal of Pharmacology|September 24, 2014
Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminusAisling M Lynch, Nupur Pathak, Yasmin E Flatt, et al.
Pageof 10